Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Diverticulitis 1Crohn Disease 1Colonic Polyps 1Colonic Neoplasms 1Colitis, Ulcerative 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Hydroxyethyl Starch Derivatives × Clear all
NCT00467922 2009-10-21

An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy

Corewell Health West

Phase 3 Completed
69 enrolled
Gastrointestinal

Colitis, Ulcerative, Colonic Neoplasms, Colonic Polyps, Crohn Disease, Diverticulitis, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡